The attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that begins in childhood and, in a significant proportion of cases, persists into adult life. It is not a matter of willpower or character: it affects specific functions such as sustained attention, planning, emotional regulation and impulse control. When this condition is combined with problematic use of alcohol or other substances, the result is not simply 'one thing plus another': this is a case of dual diagnosis, and that changes the way diagnosis and treatment must be approached.
In this text we explain what is known about the relationship between ADHD and addictions, why the idea of self-medication appears so frequently, how ADHD is diagnosed when there is active substance use, and what is considered regarding the most delicate question of all: whether it is advisable to treat ADHD pharmacologically in a person with an addiction. You will not find medication guidelines, doses or drug names here, as this can only be indicated and supervised by a doctor following an individual assessment.
What ADHD and addictive behaviour have in common
The two conditions share neurobiological ground. In ADHD there is an alteration of the reward circuit and of executive control that translates into two clinical features highly relevant to addiction: the impulsividad and the delay intolerance, that is, the difficulty in giving up a small, immediate reward in exchange for a larger but delayed one. Substance use offers precisely that: rapid, predictable and accessible relief.
To this foundation are added factors that are not neurological but weigh heavily on the trajectory: repeated academic or occupational failure, family conflict, self-esteem damaged after years of reproaches such as 'you're not trying hard enough', and the tendency to seek out highly stimulating environments where substance use is normalised. Vulnerability is therefore biological, psychological and social at the same time, which is why treatment cannot address only one of the three dimensions.
What is observed in clinical practice
Caution is warranted regarding percentages, as many circulate without proper support and vary enormously from one study to another depending on the main substance, the country and the diagnostic instrument used. What is consistent, however, is the direction of the finding: ADHD is clearly overrepresented among those seeking treatment for an addiction, and its presence is associated with an earlier onset of substance use, a more severe course, greater functional impairment and poorer treatment retention.
What cannot be stated is that ADHD «causes» addiction. It is a risk factor, not a destiny: many people with ADHD never develop a substance use problem, and many people with addiction do not have ADHD. Any figure presented as definitive and without reference to its source should be treated with caution.
The self-medication hypothesis: what it explains and what it does not
It is common to hear that the person with ADHD uses substances to «calm down», to «be able to concentrate» or to «quiet the mind». This idea has clinical value because it accurately describes the subjective function that substance use serves: it is not used solely for pleasure, but to correct a discomfort that has been present for years. Understanding that function is essential, because if treatment removes the substance without offering anything to cover that need, the risk of relapse increases.
But the hypothesis has limits that must be stated. First, it does not explain all patterns of use: some substances do not relieve any ADHD symptom and their use responds to other factors. Second, the relief is short-lived: sustained use worsens sleep, attention and emotional regulation, so that in the medium term it aggravates exactly what it was supposedly meant to resolve. And third, using it as the sole explanation leads to a common mistake: assuming that treating the ADHD is enough for the addiction to resolve on its own. This is not the case. The clinical task is to recognise the function of substance use without validating substance use as a solution.
The problem of diagnosing ADHD during active substance use
Here lies one of the greatest technical difficulties. Intoxication, withdrawal and chronic use produce symptoms that mimic ADHD: restlessness, irritability, difficulty concentrating, insomnia, forgetfulness, emotional lability. Diagnosing ADHD in the midst of active use, or during very recent withdrawal, carries a high risk of falso positivo.
This is why the procedure must be carried out systematically:
- Cribado sistemático of ADHD in people attending treatment for addiction, and of substance use in people being treated for ADHD.
- Not mistaking a questionnaire for a diagnosis: screening provides orientation, but diagnosis requires a clinical interview.
- Retrospective reconstruction of development: checking whether symptoms were present in childhood, before any substance use existed.
- Information from third parties: family, partner, school or work reports.
- Reassessment after a period of stabilisation, when the case allows it, in order to separate the noise caused by substance use from the underlying disorder.
The purpose of this rigour is not to delay help. In fact, the opposite extreme is also poor practice: waiting indefinitely for impeccable abstinence to assess ADHD leaves the person without the very tools they need to sustain the addiction treatment.
Can ADHD be treated if there is an addiction?
This is the question that most concerns patients and families, and it is legitimate that it should. The two usual fears are misuse or diversion of the medication, and the possibility of reactivating substance use.
It is a medical decision, individual and always integrated within a psychosocial treatment, never an isolated intervention. In clinical practice there are conditions that are not negotiable:
- The indication, choice and monitoring are decisión del médico, following an assessment that includes medical and psychiatric history.
- The doctor can assess presentations with lower potential for misuse, and care is taken to ensure that access to the medication does not go uncontrolled.
- Dispensing may require supervision, sometimes with family support, especially at the outset.
- Signs of escalation, diversion or non-prescribed use are actively monitored, and the regimen is reviewed periodically.
- Non-stimulant options exist, which the doctor can consider according to each person's profile.
- Treatment of the substance use is not set aside while ADHD is treated: both lines of treatment progress simultaneously.
What is never reasonable is to decide, start, stop or adjust a medication on one's own, or to take medication that was prescribed for someone else. It is one of the highest-risk scenarios.
Psychological treatment: where the underlying work takes place
Medication, when indicated, can improve the capacity to pay attention and to curb impulsivity, although the response varies from person to person. It does not teach someone to live without the substance. That learning is psychotherapeutic, and in dual pathology it has its own particular features:
- Adaptar el formato: structured sessions, specific objectives, written material and reminders. When there are attentional difficulties, a highly verbal therapy with little structure can be more difficult to make use of.
- Treating impulsivity as a symptom, not as a moral failing: identifying the interval between impulse and action and working to lengthen it.
- Emotional regulation: many relapses do not arise from a desire to use, but from an intense emotion that is difficult to sustain at that moment.
- Relapse prevention through anticipation of scenarios: identifying risk situations, times, people and environments, and rehearsing a specific response.
- Organisation of daily life: sleep, routines, time management and money management. In ADHD, disorganisation of daily life can favour relapse.
- Family or couple intervention: psychoeducation to distinguish which behaviours stem from ADHD, which from substance use, and which from the dynamic between the two.
Coordination between the medical team and the psychology team is not an organisational detail: it is part of the treatment. When the two lines work separately, each one typically attributes to the other what is not improving, leaving the person caught in the middle.
Prevention: why it matters before any use occurs
In families with a history of ADHD or addiction, prevention has clinical, not merely educational, relevance:
- Detecting and treating ADHD in good time, because untreated ADHD leaves the person exposed for years to their own impulsivity.
- Rigorous and non-judgemental psychoeducation: fear-based messages tend to be ineffective in adolescents.
- Training frustration tolerance and emotional regulation before distress seeks a chemical shortcut.
- Attending to academic performance and self-esteem, which are genuine protective factors.
- Controlling access to any medication at home and never sharing it between siblings or friends.
How we approach it at UniAdic
At UniAdic we treat ADHD associated with substance use within our dual pathology programme, with the medical and psychological team working on the same case and with shared criteria. The way we organise this process, from the initial assessment to the maintenance phase, is what we call the Unified Transdiagnostic Model (UTM).
The process includes differential diagnostic assessment, medical evaluation, individual psychotherapy and family intervention. Treatment is outpatient in most cases and, when the clinical situation requires it, admission may be considered. We are a private healthcare centre and the process is confidential from start to finish.
When it is advisable to request an assessment
It is worth seeking consultation if you have spent years with attentional difficulties, disorganisation or impulsivity and substance use has gradually become a way of getting through the day; if you have been diagnosed with ADHD and use has increased since then; if you have tried to stop and the difficulty has been maintaining the change over time; or if within your family you observe that treatment of one of the two issues never quite works because the other remains active.
If you recognise yourself in any of this, you can request a first assessment with a healthcare professional from the team. You can do it at our centre in Chamberí, Madrid, or by video call if that is more convenient for you or if you live outside Madrid.
Would you prefer that we call you?
Leave us your name and phone number and we will call you. The service is confidential.
O llámanos al 919 931 645 · Monday to Friday from 10:00 to 22:00 and Saturdays from 10:00 to 15:00.
